Hui Tian
- Topics
- MicroRNA in disease regulation (5 papers)Virus-based gene therapy research (4 papers)Virology and Viral Diseases (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hui Tian
21 papers receiving 520 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 219
- Immunology 126
- Plant Science 123
- Genetics 96
- Cancer Research 74
Countries citing papers authored by Hui Tian
This map shows the geographic impact of Hui Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Tian more than expected).
Fields of papers citing papers by Hui Tian
This network shows the impact of papers produced by Hui Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Tian. The network helps show where Hui Tian may publish in the future.
Co-authorship network of co-authors of Hui Tian
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Tian. A scholar is included among the top collaborators of Hui Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Tian. Hui Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | A novel NSUN5/ENO3 pathway promotes the Warburg effect and cell growth in clear cell renal cell carcinoma by 5-methylcytosine-stabilized ENO3 mRNA. | 2 |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 7 | |
| 5 | 9 | |
| 6 | 126 | |
| 7 | 139 | |
| 8 | 9 | |
| 9 | 17 | |
| 10 | 9 | |
| 11 | 21 | |
| 12 | 1 | |
| 13 | 38 | |
| 14 | 4 | |
| 15 | 1 | |
| 16 | 74 | |
| 17 | 42 | |
| 18 | 7 | |
| 19 | 14 | |
| 20 | [Establishment of bacteria display technology for Fab antibody library screening]. | 4 |
About Hui Tian
Hui Tian is a scholar working on Cancer Research, Animal Science and Zoology and Immunology, having authored 21 papers that have together received 538 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Virus-based gene therapy research (4 papers) and Virology and Viral Diseases (3 papers). The work is most often cited by research in Immunology (126 citations), Animal Science and Zoology (50 citations) and Cancer Research (74 citations). Hui Tian has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zijing Liu, Yixi Bao, Youwei Pu, Xing Zhou, Tingting Long, Shuang Yu, Guiping Ren, Fuliang Bai, Deshan Li and Qingzhong Yu. Their work appears in journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.